Abstract: The present disclosure provides for use of variants of C-type natriuretic peptide (CNP), and novel pharmaceutical compositions and formulations comprising CNP variant peptides for the treatment of skeletal dysplasias, one or more symptoms of skeletal dysplasias, such as long bone growth or growth velocity, and other disorders having a skeletal dysplasia and/or CNP-associated symptom or component.

Abstract: An end-effector of a programmable motion device is disclosed. The end-effector includes a body that provides an open interior, the open interior being coupled to a vacuum source, and the body including a contact surface for contacting an object to be grasped by the end effector. The contact surface includes at least one aperture through which a vacuum is provided, and the body includes an outer surface that faces away from the open interior. The body provides that when the flow of air drawn by the vacuum source through the at least one aperture is reduced due to the at least one aperture being at least partially blocked, the outer surface of the body engages the object being grasped at least partially within the open interior of the body.

Abstract: An end-effector for a programmable motion device is disclosed. The end effector includes a body that includes a contact portion, the body providing an open interior through which a vacuum may be provided to the contact portion, and the body includes at least one feature that is adapted to facilitate the contact portion to become substantially non-planar while grasping.

Abstract: An end-effector for a programmable motion device is disclosed. The end effector includes a body that includes a contact portion, the body providing an open interior through which a vacuum may be provided to the contact portion, and the body including at least one feature that is adapted to facilitate the contact portion to become substantially non-planar while grasping.

Abstract: The present disclosure provides for use of variants of C-type natriuretic peptide (CNP), and novel pharmaceutical compositions and formulations comprising CNP variant peptides for the treatment of skeletal dysplasias, one or more symptoms of skeletal dysplasias, such as long bone growth or growth velocity, and other disorders having a skeletal dysplasia and/or CNP-associated symptom or component.

Abstract: An audio signal attenuation system and method for detecting an audio emergency warning signal (or alarm) in a vehicle in which an audio signal is being played. Embodiments of the system and method make it easier for a police, fire, or other emergency alarm or siren to be heard in a loud or noisy listening environment when audio signal is being reproduced. This is achieved using selective frequency attenuation, which identifies a frequency of the alarm and then selectively attenuates the alarm frequency in the audio signal. Moreover, direction data that includes information about from which direction the alarm is coming can be used to selectively attenuate the alarm frequency in certain channels (or speakers) of the audio signal. In some embodiments, audio cues are used to alert the listener to the alarm signal and are adjusted based on alarm distance from the vehicle, speed, and the type of alarm.

Abstract: An apparatus includes a first squelch circuit and a second squelch circuit. The first squelch circuit is configured to detect possible squelch signals in a communication signal. The second squelch circuit is configured to selectively detect the possible squelch signals in the same communication signal. The second squelch circuit is further configured to operate in a low-power state responsive to the first squelch circuit detecting none of the possible squelch signals in the communication signal. The second squelch circuit is further configured to operate in a high-power state responsive to the first squelch circuit detecting one of the possible squelch signals in the communication signal.

Abstract: An audio signal attenuation system and method for detecting an audio emergency warning signal (or alarm) in a vehicle in which an audio signal is being played. Embodiments of the system and method make it easier for a police, fire, or other emergency alarm or siren to be heard in a loud or noisy listening environment when audio signal is being reproduced. This is achieved using selective frequency attenuation, which identifies a frequency of the alarm and then selectively attenuates the alarm frequency in the audio signal. Moreover, direction data that includes information about from which direction the alarm is coming can be used to selectively attenuate the alarm frequency in certain channels (or speakers) of the audio signal. In some embodiments, audio cues are used to alert the listener to the alarm signal and are adjusted based on alarm distance from the vehicle, speed, and the type of alarm.

Abstract: Apparatus having corresponding methods comprise: a first squelch circuit configured to detect possible squelch signals in a communication signal; and a second squelch circuit configured to i) operate in a low-power state responsive to the first squelch circuit detecting none of the possible squelch signals in the communication signal, and ii) operate in a high-power state responsive to the first squelch circuit detecting one of the possible squelch signals in the communication signal.